Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
The University of Western Australia holds a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. There are 2 pending office actions currently active. These 2 pending office actions are distributed among 2 distinct examiners, which means each matter is being reviewed by a different person. This spread of responsibility can lead to a variety of outcomes across the portfolio.
The prosecution is active in 2 distinct art units. FRONDA, CHRISTIAN L is the busiest examiner, responsible for 1 busiest examiner pending office action. This examiner is one of the 2 distinct examiners currently assigned to the university's cases. The presence of 2 distinct art units suggests that the university's technical focus within Biotechnology & Pharmaceuticals is spread across several specific areas. Practitioners should coordinate their efforts across the 2 distinct examiners to maintain a unified approach. The fact that 1 busiest examiner pending office action is the maximum for any single examiner indicates an even distribution of the current workload. Navigating the requirements of 2 distinct art units will be key to successful prosecution.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FRONDA, CHRISTIAN L | 1 | 82.5% | +14.3% |
| WU, JULIE ZHEN QIN | 1 | 62.5% | +50.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18802964 | Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE) | FRONDA, CHRISTIAN L | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17312317 | Screening Assays, Modulators and Modulation of Intracellular Signalling Mediated by Immunoglobulin Superfamily Cell Adhesion Molecules | WU, JULIE ZHEN QIN | 12d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17312317 | Screening Assays, Modulators and Modulation of Intracellular Signalling Mediated by Immunoglobulin Superfamily Cell Adhesion Molecules | WU, JULIE ZHEN QIN | 12d |
| 18802964 | Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE) | FRONDA, CHRISTIAN L | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| 1643 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18802964 | Screening Assays, Modulators and Modulation of Activation of Receptor for Advanced Glycation End-Products (RAGE) | FRONDA, CHRISTIAN L | 1652 | §103DP | Non-Final OA | — | Pending | Aug 13, 2024 |
| 17312317 | Screening Assays, Modulators and Modulation of Intracellular Signalling Mediated by Immunoglobulin Superfamily Cell Adhesion Molecules | WU, JULIE ZHEN QIN | 1643 | §102§103§112 | Final Rejection | 12d | Pending | Jun 09, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe University of Western Australia has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Christian L Fronda has the most, with 1 of The University of Western Australia's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
